1. Synthesis and pharmacological evaluation of 1,1,3-substituted urea derivatives as potent TNF-alpha production inhibitors
- Author
-
Chikako Setoguchi, Hiroyuki Inoue, Yoshimasa Sasabuchi, Ayako Sawa, Noriyoshi Yamamoto, Masahiro Okamoto, Hiroshi Suhara, Hiroshi Enomoto, Fumio Tsuji, Masakazu Ban, and Masato Horiuchi
- Subjects
Lipopolysaccharide ,Stereochemistry ,Pyridines ,Tumor Necrosis Factor-alpha ,Organic Chemistry ,Clinical Biochemistry ,Substituent ,Pharmaceutical Science ,Administration, Oral ,Biochemistry ,Chemical synthesis ,Sulfenic Acids ,Proinflammatory cytokine ,Rats ,chemistry.chemical_compound ,chemistry ,Oral administration ,Drug Discovery ,Urea ,Molecular Medicine ,Moiety ,Animals ,Tumor necrosis factor alpha ,Molecular Biology - Abstract
A three substituted urea derivative, SA13353 (compound 1a), exhibited potent inhibitory activity against lipopolysaccharide (LPS)-induced TNF-alpha production. We focused on the 1,1-substituted moiety (R(1) and R(2)) of SA13353 and investigated substituent effects of this moiety on LPS-induced TNF-alpha production by oral administration in rats. The synthesis of the urea derivatives was performed rapidly in a one-pot manner using a manual synthesizer. Several compounds containing hydrophobic substituents at this moiety showed more potent inhibitory activities than SA13353.
- Published
- 2010